A Study of the Efficacy and Safety of MEDI7352 in Subjects with Painful Osteoarthritis of the Knee - BESPOKE

Study identifier:D5680C00003

ClinicalTrials.gov identifier:NCT04675034

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

: A Randomised, Double-blind, Placebo-controlled, Dose-response Study of the Efficacy and Safety of MEDI7352 in Subjects with Painful Osteoarthritis of the Knee:

Medical condition

Painful osteoarthritis of the knee

Phase

Phase 2

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

345

Study type

Interventional

Age

18 Years - 80 Years

Date

Study Start Date: 02 Dec 2020
Estimated Primary Completion Date: 14 Aug 2023
Estimated Study Completion Date: 14 Aug 2023

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: -
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria